Tag: Canntab
-
Canntab Therapeutics (PILL.C) Enters Agreement with 36Eight Technologies
Canntab Therapeutics (PILL.C) announced today that it has reached an agreement with 36Eight Technologies (“36Eight”), whereby “36Eight” will list, market, and support all of Canntab’s market-exclusive and patent-protected solid and exact dose products. “This is an exciting opportunity for Canntab, as we believe 36Eight’s unique and valuable complementary platform will support our ability to provide…
-
Canntab (PILL.C) yeets another patent for hard-pressed, long release cannabis pills
I’ve made no secret of the fact that the Canadian cannabis market frequently annoys the hell out of me. What I want is for it to be a mature space that more and more adults are making use of, and that is free to innovate, free to be excellent, free to market itself properly, and…
-
Canntab Therapeutics’ (PILL.C) bursts out of the starting blocks with $1.3 million sale
PILL is developing solid oral dose formulations of cannabis with a product line of cannabinoid (THC & CBD) and terpenoid blends in multiple doses and timed-release combinations
-
World Class Extractions (PUMP.C) partners with Canopy’s (WEED.T) medical division
“Spectrum Therapeutics’ medical patients can have confidence that their legal cannabis purchases will arrive at their door in a safe and timely fashion,” stated Rosy Mondin, CEO of World-Class
-
World Class (PUMP.C) spikes 25% on agreement to purchase Pineapple Express
March, 2020 PED revenues increased 265% from those in January, 2020 – as the company’s operations ramp up to satisfy growing demand.
-
World Class (PUMP.C)/Canntab JV receives cannabis extraction licences
World Class has begun to deliver the BOSS C02 Extraction Systems along with peripheral equipment to Canntab’s Markham facility. The facility is fully scalable – further BOSS systems are expected to be deployed as demand increases.